医学
狭窄
血管内治疗
冲程(发动机)
随机对照试验
药物治疗
血运重建
重症监护医学
外科
放射科
内科学
动脉瘤
机械工程
工程类
心肌梗塞
作者
Theresa Elder,Timothy G. White,Henry H. Woo,Adnan H. Siddiqui,Ravi S. Nunna,Farhan Siddiq,Giuseppe Esposito,Daniel Chang,Nestor R. Gonzalez,Sepideh Amin‐Hanjani
出处
期刊:Stroke
[Ovid Technologies (Wolters Kluwer)]
日期:2024-01-22
卷期号:55 (2): 344-354
被引量:6
标识
DOI:10.1161/strokeaha.123.043634
摘要
Intracranial atherosclerotic disease and resultant intracranial stenosis is a global leading cause of stroke, and poses an ongoing treatment challenge. Among patients with intracranial stenosis, those with hemodynamic compromise are at high risk for recurrent stroke despite medical therapy and risk factor modification. Revascularization of the hypoperfused territory is the most plausible treatment strategy for these high-risk patients, yet surgical and endovascular therapies have not yet shown to be sufficiently safe and effective in randomized controlled trials. Advances in diagnostic and therapeutic technologies have led to a resurgence of interest in surgical and endovascular treatment strategies, with a growing body of evidence to support their further evaluation in the treatment of select patient populations. This review outlines the current and emerging endovascular and surgical treatments and highlights promising future management strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI